Partner Aaron Tantleff was quoted in a CSO article, “Open Source: Big Benefits, Big Flaws,” on June 15, 2015. The article discussed open source as a dominant force in IT, yet its benefits – free, open customizable and overseen by a community of users – can make it risky. Tantleff shared insights on utilizing open source while avoiding the downfalls, and was quoted saying, “Companies should treat open source like all other software. It is important that one knows where the software is coming from – that it’s a trusted source. You should also gather diligence on the software from other trusted sources.”
People
Related News
May 1, 2026
In the News
David Rosen Weighs in on SCOTUS Review of Skinny Label Patent Dispute
Foley & Lardner LLP partner David Rosen is featured across the media for his perspective on the U.S. Supreme Court case Hikma Pharmaceuticals v. Amarin Pharma.
April 27, 2026
In the News
Jesse Neil Featured as a Distinguished Leader in Law.com's Southeastern Legal Awards
Foley & Lardner LLP partner Jesse Neil is recognized in Law.com as one of the Distinguished Leader honorees for the 2026 Southeastern Legal Awards.
April 27, 2026
In the News
David Rosen and William Holtz Analyze FDA Approval Speed, Biotech Pressures
Foley & Lardner LLP attorneys David Rosen and William Holtz are quoted in the PharmaVoice article, “FDA’s need for speed could strain small biotechs. Here’s how they can keep up,” examining the FDA’s accelerated drug approval initiatives and its impact on smaller pharmaceutical companies.